Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam

In the present study piroxicam loaded starch nanoparticles were prepared to enhance the solubility of piroxicam by nanoprecipitation technique. The preparation of nanoparticles was carried out as per central composite experimental design protocol, having concentration of starch and drug as independe...

Full description

Bibliographic Details
Main Authors: Meenakshi Bhatia, Sulekha Rohilla
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S131901642030133X
id doaj-dfc65a53a195481fbdef4349b2809276
record_format Article
spelling doaj-dfc65a53a195481fbdef4349b28092762020-11-25T02:47:49ZengElsevierSaudi Pharmaceutical Journal1319-01642020-08-01288927935Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicamMeenakshi Bhatia0Sulekha Rohilla1Corresponding author.; Guru Jambheshwar University of Science and Technology, Hisar 125 001, IndiaGuru Jambheshwar University of Science and Technology, Hisar 125 001, IndiaIn the present study piroxicam loaded starch nanoparticles were prepared to enhance the solubility of piroxicam by nanoprecipitation technique. The preparation of nanoparticles was carried out as per central composite experimental design protocol, having concentration of starch and drug as independent variables and particle size and polydispersity index (PdI) as dependent variables. The particle size and PdI of piroxicam loaded starch nanoparticles was found to be between 282–870 nm and 0.339–0.772, respectively. After the characterization by FT-IR, TGA, XRD and SEM studies, the optimized batch was evaluated for in-vitro release study, anti-inflammatory activity and anti-oxidant activity. The in-vitro anti-inflammatory activity of piroxicam loaded starch nanoparticles was found to be more than the pure drug piroxicam whereas the anti-oxidant activity of starch is found greater than starch nanoparticles. In-vitro release study showed 98.8% release in 2 h dissolution study following supercase II transport mechanism of drug release.http://www.sciencedirect.com/science/article/pii/S131901642030133XQuinoa starchPiroxicamNanoprecipitationAnti-oxidantIn-vitro anti-inflammatorySolubility enhancement
collection DOAJ
language English
format Article
sources DOAJ
author Meenakshi Bhatia
Sulekha Rohilla
spellingShingle Meenakshi Bhatia
Sulekha Rohilla
Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam
Saudi Pharmaceutical Journal
Quinoa starch
Piroxicam
Nanoprecipitation
Anti-oxidant
In-vitro anti-inflammatory
Solubility enhancement
author_facet Meenakshi Bhatia
Sulekha Rohilla
author_sort Meenakshi Bhatia
title Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam
title_short Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam
title_full Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam
title_fullStr Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam
title_full_unstemmed Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam
title_sort formulation and optimization of quinoa starch nanoparticles: quality by design approach for solubility enhancement of piroxicam
publisher Elsevier
series Saudi Pharmaceutical Journal
issn 1319-0164
publishDate 2020-08-01
description In the present study piroxicam loaded starch nanoparticles were prepared to enhance the solubility of piroxicam by nanoprecipitation technique. The preparation of nanoparticles was carried out as per central composite experimental design protocol, having concentration of starch and drug as independent variables and particle size and polydispersity index (PdI) as dependent variables. The particle size and PdI of piroxicam loaded starch nanoparticles was found to be between 282–870 nm and 0.339–0.772, respectively. After the characterization by FT-IR, TGA, XRD and SEM studies, the optimized batch was evaluated for in-vitro release study, anti-inflammatory activity and anti-oxidant activity. The in-vitro anti-inflammatory activity of piroxicam loaded starch nanoparticles was found to be more than the pure drug piroxicam whereas the anti-oxidant activity of starch is found greater than starch nanoparticles. In-vitro release study showed 98.8% release in 2 h dissolution study following supercase II transport mechanism of drug release.
topic Quinoa starch
Piroxicam
Nanoprecipitation
Anti-oxidant
In-vitro anti-inflammatory
Solubility enhancement
url http://www.sciencedirect.com/science/article/pii/S131901642030133X
work_keys_str_mv AT meenakshibhatia formulationandoptimizationofquinoastarchnanoparticlesqualitybydesignapproachforsolubilityenhancementofpiroxicam
AT sulekharohilla formulationandoptimizationofquinoastarchnanoparticlesqualitybydesignapproachforsolubilityenhancementofpiroxicam
_version_ 1724751056789831680